Dr. Sheybani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4901 Forest Park Ave
Fl 6
Saint Louis, MO 63108Phone+1 314-362-3937Fax+1 314-362-3725
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2009 - 2012
- Mercy Hospital (St Louis)Internship, Transitional Year, 2008 - 2009
- Washington University in St. Louis School of MedicineClass of 2008
Certifications & Licensure
- MO State Medical License 2012 - 2026
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation.Vanessa Vera, Arsham Sheybani, Joseph F Panarelli, Davinder S Grover, James Lee
Clinical Ophthalmology. 2025-01-01 - Migraine is a risk factor for pseudophakic positive dysphotopsia following monofocal lens implantation.Maggie J Xing, Thiago A Moulin, Tara Suresh, Joseph P Gira, Arsham Sheybani
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024-12-01 - Three techniques for 360-degree gonioscopy-assisted transluminal trabeculotomy with iTrack advance.Sean Smith, Jessie Wang, Shivani Kamat, Arsham Sheybani, Ian Patterson
American Journal of Ophthalmology Case Reports. 2024-12-01
Authored Content
- Nearly 20% of Glaucoma Surgeries for POAG Fail After 5 YearsFebruary 2022
Press Mentions
- Iantrek Announces Publication Highlighting 12-Month Results for Its Bio-Interventional Uveoscleral Outflow TechnologyOctober 12th, 2024
- Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma PatientsSeptember 17th, 2024
- Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP VariationNovember 15th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: